# Step 1.1 Interview Notes

## What was implemented?
A complete product-definition baseline for CareFlow Health: vision, scope, user roles, modules, user journeys, requirements strategy, QA strategy, synthetic data strategy, AI/RAG relevance, and traceability template.

## Why was this step necessary?
To avoid building UI/automation from assumptions and to establish consistent requirement semantics before BRD/PRD authoring.

## Why create requirements without an existing BRD/PRD?
Because this project starts from zero artifacts; Step 1.1 defines the product contract and strategy so BRD/PRD in subsequent steps are coherent and traceable.

## How would you explain CareFlow Health?
CareFlow Health is a frontend-only healthcare management portal simulation used as the system under test for QA automation and AI QA engineering workflows.

## Why frontend-only?
It aligns with project constraints and focuses effort on realistic UI behavior, automation, and AI-driven quality workflows without backend dependencies.

## Why synthetic healthcare data?
To enforce compliance/safety: no PHI, no real patient records, and deterministic testability.

## How does the requirements hierarchy work?
Product Vision -> BRD -> PRD -> Epics -> User Stories -> Acceptance Criteria -> Business Rules -> Test Scenarios -> Test Cases -> Automation.

## How will RAG use these artifacts?
As curated knowledge sources for grounded requirement lookup, traceability support, and QA context retrieval.

## How will the AI Agent use these artifacts?
For requirement analysis, test generation support, coverage reasoning, and failure-to-defect workflow support in future phases.

## Interview Questions
1. Why define product strategy before BRD/PRD?
2. How do you prevent scope drift in a long multi-phase project?
3. Why is API testing out of scope here?
4. How does traceability improve QA outcomes?
5. What risks are reduced by synthetic data policy?

## Suggested Answers
- Strategy-first prevents inconsistent requirement decomposition.
- Scope/non-goals and standards documents are explicit controls.
- Architecture is intentionally frontend-only; API testing is not applicable.
- Traceability links requirements to automation and defect evidence.
- Synthetic data removes PHI/legal risk and improves reproducibility.

## 30-second explanation
Step 1.1 defines CareFlow Health as a realistic frontend-only healthcare product and establishes the requirements strategy, QA strategy, and traceability foundation for all subsequent BRD/PRD and automation steps.

## 1-minute explanation
I created product-definition artifacts before any feature implementation: vision, scope boundaries, user roles, modules, journeys, and requirement hierarchy. I also added QA strategy with API testing explicitly not applicable, plus synthetic data and AI relevance strategies. This gives a controlled base for BRD/PRD and future automation/RAG/agent workflows.

## 2-minute explanation
This step is the contract between architecture intent and future delivery. Instead of jumping into BRD/PRD directly, I established product vision and strategic requirements decomposition for CareFlow Health. I documented roles, module boundaries, operational journeys, and explicit in/out scope to prevent architecture drift. I added a requirements hierarchy and traceability template that map directly to future test design and automation. I also captured QA strategy tailored for frontend-only constraints and defined how future RAG/AI workflows consume these artifacts. The outcome is a reproducible, interview-ready foundation with clear non-goals (no backend/APIs/PHI) and clear next steps (BRD then PRD).

## Resume bullet
Defined product vision and requirements strategy for a frontend-only healthcare portal (CareFlow Health), including role-based journeys, traceability model, QA strategy, and AI-ready requirement architecture.
